CSL Behring LLC is a biotherapeutics company that makes recombinant, plasma-derived, and cell and gene therapies. Its filings show it lobbies Congress on Medicare and Medicaid rules and broader health issues, including laws and policies affecting plasma-derived therapies and the PLASMA Act (H.R.1476/S.694). It has reported $160,000 in lobbying since 4 filings and hired SplitOak Strategies LLC.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
SARAH KUEHL EGGE
The latest disclosures for this client.
SPLITOAK STRATEGIES LLC
Q2SPLITOAK STRATEGIES LLC
Q1The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
SPLITOAK STRATEGIES LLC
SPLITOAK STRATEGIES LLC
Q4SPLITOAK STRATEGIES LLC
Q3SPLITOAK STRATEGIES LLC
Q2SPLITOAK STRATEGIES LLC
Q1